Design, setting, randomization, blinding
CONSOLIDATION, RECRUITMENT
This study is a parallel randomized clinical trial including an intervention and control group. Reporting of this study is in accordance with the Consolidation Standards of Reporting Trials (CONSORT) statement (Supplementary file The researchers first identified eligible individuals using convenience sampling and provided them with the necessary explanations on the study process. Those who agreed to take part were then invited to give their informed consent and enrolled. The recruitment period lasted 6 months. The intervention period began in August 2021. Follow-up data collection ended in January 2022.Eligible participants were assigned to one of two groups (intervention and control) using the block randomization method at a ratio of 1:1 (available at Blinding was not possible due to the nature of the interventions. Yet, the data collection tool was used by a research assistant who had no knowledge of the study groups and their allocation. Furthermore, statistical analysis was performed by a statistician who also had no knowledge of the content provided for each of the study groups and their allocation.